Skip to main content

Table 1 Basic clinical and laboratory characteristics of the study groups

From: High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus

Characteristics

SLE patients (n = 51)

Controls (n = 49)

P Value

Gender (female/male)

44/7

41/8

0.717

Age (yr)

31.82 ± 6.40

31.8 ± 6.81

0.983

BMI (kg/m2)

24.45 ± 4.13

23.86 ± 4.28

0.489

Current smoker (%)

31.37

26.53

0.484

Systolic blood pressure (mmHg)

115 (110–120)

117 (110–120)

0.952

Diastolic blood pressure (mmHg)

70 (70–80)

78 (70–80)

0.592

Glucose (mmol/L)

4.89 ± 0.77

4.32 ± 0.57

<0.001

Total cholesterol (mmol/L)

4.57 ± 1.12

4.81 ± 0.80

0.222

LDL-cholesterol (mmol/L)

2.60 ± 0.84

2.71 ± 0.69

0.473

HDL-cholesterol (mmol/L)

1.26 ± 0.47

1.71 ± 0.45

<0.001

Non-HDL cholesterol (mmol/L)

3.22 ± 1.23

3.10 ± 0.78

0.573

Triglycerides (mmol/L)

1.25 (0.9-1.9)

0.90 (0.7-1.4)

0.005

Apolipoprotein A1 (g/l)

1.39 ± 0.35

1.66 ± 0.41

<0.001

Apolipoprotein B-100 (g/l)

0.86 ± 0.26

0.76 ± 0.22

0.047

Lipoprotein (a) (mg/l)

106 (29–294)

76 (29–169)

0.240

ApoA1/HDL (g/mmol)

1.17 ± 0.26

0.99 ± 0.17

<0.001

  1. Statistically significant differences are marked in bold